TE_20778
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | MSANTD3-TMEFF1, TMEFF1 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 174.02 |
| Counts of samples | TCGA_tumor:771; TCGA_normal:3; GTEx:1 |
| TSS | chr9(+):100527302 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_20778.1 | MSANTD3-TMEFF1, TMEFF1 | Chimeric | Non-coding | Non-coding | chr9(+):100527303,100527368,100547744,100547892,100550095,100550160,100561397,100561520,100572518,100572676,100576516,100576536 |
| teRNA_20778.2 | MSANTD3-TMEFF1, TMEFF1 | Chimeric | Non-coding | Non-coding | chr9(+):100527303,100527368,100550095,100550160,100561397,100561520,100572518,100572676,100576516,100576536 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
